Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial
Manuel Dote-Montero, Antonio Clavero-Jimeno, Elisa Merchán-Ramírez, Maddi Oses, Jon Echarte, Alba Camacho-Cardenosa, Mara Concepción, Francisco J. Amaro-Gahete, Juan M. A. Alcántara, Alejandro López-Vázquez, Rocío Cupeiro, Jairo H. Migueles, Alejandro De-la-O, Patricia V. García Pérez, Victoria Contreras-Bolivar, Araceli Muñoz-Garach, Ana Zugasti, Estrella Petrina, Natalia Alvarez de Eulate, Elena Goñi, Cristina Armendariz-Brugos, Maria T. González Cejudo, Jose L. Martín-Rodríguez, Fernando Idoate, Rafael Cabeza, Almudena Carneiro-Barrera, Rafael de Cabo, Manuel Muñoz-Torres, Idoia Labayen, Jonatan R. Ruiz
{"title":"Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial","authors":"Manuel Dote-Montero, Antonio Clavero-Jimeno, Elisa Merchán-Ramírez, Maddi Oses, Jon Echarte, Alba Camacho-Cardenosa, Mara Concepción, Francisco J. Amaro-Gahete, Juan M. A. Alcántara, Alejandro López-Vázquez, Rocío Cupeiro, Jairo H. Migueles, Alejandro De-la-O, Patricia V. García Pérez, Victoria Contreras-Bolivar, Araceli Muñoz-Garach, Ana Zugasti, Estrella Petrina, Natalia Alvarez de Eulate, Elena Goñi, Cristina Armendariz-Brugos, Maria T. González Cejudo, Jose L. Martín-Rodríguez, Fernando Idoate, Rafael Cabeza, Almudena Carneiro-Barrera, Rafael de Cabo, Manuel Muñoz-Torres, Idoia Labayen, Jonatan R. Ruiz","doi":"10.1038/s41591-024-03375-y","DOIUrl":null,"url":null,"abstract":"<p>The optimal eating window for time-restricted eating (TRE) remains unclear, particularly its impact on visceral adipose tissue (VAT), which is associated with cardiometabolic morbidity and mortality. We investigated the effects of three TRE schedules (8 h windows in the early day, late day and participant-chosen times) combined with usual care (UC, based on education about the Mediterranean diet) versus UC alone over 12 weeks in adults with overweight or obesity. The primary outcome was VAT changes measured by magnetic resonance imaging. A total of 197 participants were randomized to UC (<i>n</i> = 49), early TRE (<i>n</i> = 49), late TRE (<i>n</i> = 52) or self-selected TRE (<i>n</i> = 47). No significant differences were found in VAT changes between early TRE (mean difference (MD): −4%; 95% confidence interval (CI), −12 to 4; <i>P</i> = 0.87), late TRE (MD: −6%; 95% CI, −13 to 2; <i>P</i> = 0.31) and self-selected TRE (MD: −3%; 95% CI, −11 to 5; <i>P</i> ≥ 0.99) compared with UC, nor among the TRE groups (all <i>P</i> ≥ 0.99). No serious adverse events occurred; five participants reported mild adverse events. Adherence was high (85–88%) across TRE groups. These findings suggest that adding TRE, irrespective of eating window timing, offers no additional benefit over a Mediterranean diet alone in reducing VAT. TRE appears to be a safe, well-tolerated and feasible dietary approach for adults with overweight or obesity. ClinicalTrials.gov registration: NCT05310721.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"99 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-024-03375-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The optimal eating window for time-restricted eating (TRE) remains unclear, particularly its impact on visceral adipose tissue (VAT), which is associated with cardiometabolic morbidity and mortality. We investigated the effects of three TRE schedules (8 h windows in the early day, late day and participant-chosen times) combined with usual care (UC, based on education about the Mediterranean diet) versus UC alone over 12 weeks in adults with overweight or obesity. The primary outcome was VAT changes measured by magnetic resonance imaging. A total of 197 participants were randomized to UC (n = 49), early TRE (n = 49), late TRE (n = 52) or self-selected TRE (n = 47). No significant differences were found in VAT changes between early TRE (mean difference (MD): −4%; 95% confidence interval (CI), −12 to 4; P = 0.87), late TRE (MD: −6%; 95% CI, −13 to 2; P = 0.31) and self-selected TRE (MD: −3%; 95% CI, −11 to 5; P ≥ 0.99) compared with UC, nor among the TRE groups (all P ≥ 0.99). No serious adverse events occurred; five participants reported mild adverse events. Adherence was high (85–88%) across TRE groups. These findings suggest that adding TRE, irrespective of eating window timing, offers no additional benefit over a Mediterranean diet alone in reducing VAT. TRE appears to be a safe, well-tolerated and feasible dietary approach for adults with overweight or obesity. ClinicalTrials.gov registration: NCT05310721.
期刊介绍:
Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors.
Nature Medicine consider all types of clinical research, including:
-Case-reports and small case series
-Clinical trials, whether phase 1, 2, 3 or 4
-Observational studies
-Meta-analyses
-Biomarker studies
-Public and global health studies
Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.